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ABSTRACT
Reverse phase protein arrays (RPPAs) are a powerful high-
throughput tool for measuring protein concentrations in a large
number of samples. In RPPA technology, the original samples
are often diluted successively multiple times, forming dilution
series to extend the dynamic range of the measurements and
to increase conﬁdence in quantitation. An RPPA experiment is
equivalent to running multiple ELISA assays concurrently except
that there is usually no known protein concentration from which
one can construct a standard response curve. Here, we describe
a new method called ‘serial dilution curve for RPPA data analysis’.
Compared with the existing methods, the new method has the
advantage of using fewer parameters and offering a simple way of
visualizing the raw data. We showed how the method can be used
to examine data quality and to obtain robust quantiﬁcation of protein
concentrations.
Availability: A computer program in R for using serial dilution curve
for RPPA data analysis is freely available at http://odin.mdacc.tmc.
edu/∼zhangli/RPPA.
Contact: lzhangli@mdanderson.org
1 INTRODUCTION
The reverse phase protein array (RPPA) is an emerging
high-throughput technique in proteomics (for reviews, see
BorrebaeckandWingren,2007;Charboneauetal.,2002;LvandLiu,
2007; Poetz et al., 2005; Sheehan et al., 2005). This technology has
been successfully applied in a number of basic and clinical studies
(Amit et al., 2007; Aoki et al., 2007; Fan et al., 2007; Pluder et al.,
2006; Sahin et al., 2007; Tibes et al., 2006;Yokoyama, et al., 2007).
Asingle array slide can be used to measure hundreds of samples for
a protein. The protein level across the slide is detected by binding
of a highly speciﬁc and sensitive primary antibody followed by
detection using ampliﬁcation linked to ﬂuorescence, dye deposition,
near infrared or nanoshells. Because protein concentrations can vary
over many orders of magnitude in patient or cell line samples, it is
desirable to have accurate measurements of protein concentrations
over a wide dynamic range. To extend the dynamic range of the
measurements, each sample is diluted multiple times successively
∗To whom correspondence should be addressed.
and spotted on an RPPA slide so that if a protein concentration in
the original sample is close to saturation, the sample can still be
measured at diluted spots.
Multiple methods are available for analysis of RPPA data
(Huetal.,2007;Kreutzetal.,2007;Mirceanetal.,2005).Typically,
the methods are based on modeling the response curve, which
describes the relationship between the observed signal and the
protein concentration. Mircean et al. (2005) realized that since it
is the same protein being measured for all the samples spotted
on an RPPA slide, the same response curve should be suitable
for all these samples. Based on this assumption, Microean et al.
proposed a robust linear-square method to quantify the protein
levels. However, an obvious drawback of the method is that it fails
to recognize saturation effects for proteins at high levels. Recently,
Hu et al. (2007) developed an alternative method using a non-linear,
non-parametric approach to model the response curve.
In this study, we show an alternative approach to RPPA data
analysis.Insteadofmodelingtheresponsecurve,weconstructanew
model, serial dilution curve, which characterizes the relationship
between signals in successive dilution steps. The advantage of this
approach is two fold: (i) the signals in successive dilutions can be
related to each other in explicit formula in which the underlying
unknown protein concentrations do not appear. This allows a low-
dimensional non-linear optimization to estimate the key parameters
of the map between protein concentration and signal intensity. The
estimatedmapcanthenbeappliedtotheobservedsignalstoestimate
the underlying abundances; (ii) it leads to an intuitive display of raw
data, which is very useful for checking data quality and interpreting
the model.
2 METHODS
2.1 Serial dilution curve
Our new method is based on the recognition that the relationship between
signals in successive dilution steps uniquely determines the response curve.
Typically, a response curve is a monotonic, s-shaped curve. It can be
described by the Sips model (Sips, 1948):
S=a+bxγ/[1+xγ/(M−a)] (1)
where a is the background noise; b is the response rate in the linear range;
M is the maximum or saturation level, x is the concentration of the protein.
Sips model has been widely used to describe adsorption including binding
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of DNA(Glazer et al., 2006) and proteins on solid surface (Vijayendran and
Leckband, 2001). Generally, γ =1 applies to conditions in which the free
energy of binding of the solute molecules can take a range of values instead
of a unique value (Sips, 1948), i.e. there is some hereterogeneity in the
solute molecules or the surface receptors. When the range of the free energy
of binding shrinks to a singular point, γ approaches to 1, in which case it is
equivalent to the conventional Langmiur model. With RPPAtechnology, one
can only determine the relative protein concentration. Thus, x can be chosen
on an arbitrary scale. For simplicity, we set x on a scale (i.e. a physical unit
of x) so that b=1. Thus,
S=a+xγ/[1+xγ/(M−a)] (2)
On this scale, protein concentration equals the background subtracted signal
(S−a) when γ=1 and saturation effect can be ignored.
Starting from Equation (2), we can see that if the protein concentration is
diluted from x to x/dk at the k-th dilution step, where d >1, the expected
signal would be:
Sk =a+(x/dk)γ/[1+(x/dk)γ/(M−a)] (3)
Combine the cases for Sk+1 and Sk and eliminate x, we have:
Sk =a+dγ(Sk+1−a)/[1+(dγ−1)(Sk+1−a)/(M−a)] (4)
Equation (3) describes Sk as a function of Sk+1, which we call the serial
dilution curve, with three unknown parameters: a, M and γ (d is known).
These parameters have graphical interpretations from the plot. As shown
in Figure 1, the curve has two intersection points with identity line: one
at background level, Sk =Sk+1=a, the other at the saturation level, Sk =
Sk+1 =M. At the left side in Figure 1, the saturation effect is of no concern
and the relationship between Sk and Sk+1 is approximately linear,
Sk−a≈dγ(Sk+1−a). (5)
Thus, dγ corresponds to the slope in the linear range in the serial dilution
plot.
Equation (4) suggests a new model for displaying and analyzing RPPA
data. It is important to note that Equation (4) does not contain protein
concentration. Thus, it permits an appealing way of displaying the raw
data without model speciﬁcation or parameterization. Based on the plot like
Figure 1, we can infer the parameters (a, M and γ) from the graph or through
model ﬁtting without knowing the protein concentrations in the samples.
Fig. 1. Serial dilution plot. Each point in the serial dilution plot is composed
of an observed signal Sk at dilution step k (on x-axis) and a corresponding
signal Sk +1 of the same sample at the dilution step k +1 (on y-axis). The
curvewasproducedusingEquation(3).Thecurvehastwointersectionpoints
with the identity line: (a,a) and (M,M).
Model ﬁtting with Equation (4) is relatively simpler than that with model
ﬁtting with Equation (2), which involves much more unknown parameters
as in the existing methods of RPPA data analysis. Altogether, the number
of unknown parameters in the model with Equation (2) is three plus the
number of protein samples (each dilution series count as one sample), which
canbeinthehundreds.Incontrast,Equation(4)onlyinvolvesthreeunknown
parameters.
2.2 Parameterization of the serial dilution curve
To ﬁnd the optimal parameters, we used a weighted non-linear regression
modelusingEquation(4)asthemodelandtakinga,D=dγ,M asparameters.
We assumed the observed signals have multiplicative errors except for the
signals close to zero. The weight used in the regression model is 1/(m+|S|),
where m=5, which is taken as the minimal error from signal quantiﬁcation
from the scanner used to obtain RPPA data. The starting values of a, D
and M were taken to be max(m, min(S)), d, max(S), respectively. The nls
function implemented in R-language (Ihaka and Gentleman, 1996) was used
to optimize the parameters. The m is set to be the lower bound of a.
2.3 Estimating protein concentrations
Given the parameters in Equation (4) and signals of a dilution series
of a particular sample (let these be S0,S1,S2,...,SK), to obtain protein
concentration ˆ x in the original undiluted sample, we used the following
procedure. First, if all these signals are greater than M/r, the protein
concentration ˆ x is marked to be saturated.
This threshold value of M/r is set according to an approximate estimate of
the 95% conﬁdence interval (CI) of the signals at the saturated spots. Under
multiplicative error model, assume that the error rate of the observed signals
is ε=10%, and the saturation level is M, we expect the CI to be [M/(1+
2×ε), M(1+2×ε) ]=[ M/1.2,1.2M]. Similarly, at background level a,
we expect the 95% CI to be [a/(1+2×ε), a(1+2×ε)] = [a/1.2,1.2a].
In general, r should be >1 and can be reduced if precision of signals is
improved.
If all the signals except one are >M/r and the exception is not SK, ˆ x is
also marked to be saturated. Similarly, if all the signals are <ar, ˆ x is marked
to be undetected. If all of them except one are >M/r and the exception is
not S0, ˆ x is also marked to be undetected. The minimum and maximum of ˆ x
are set to be
xmin=[1/(ar−a)−1/(M−a)]−1/γ and (6)
xmax=[1/(M/r−a)−1/(M−a)]−K/γ, (7)
respectively. The above steps were taken to stabilize the protein
concentration estimates for out of linear-range measurements.
If ˆ x isnotmarkedsaturatedorundetected,weproceedtomakeanestimate
of ˆ x. We choose to remove signals >M/r or <ar. Then, we convert each of
the remaining signals Sj to xj as
xj=dj[1/(Sj−a)−1/(M−a)]−1/γ (8)
where j denotes the j-th dilution step. To remove outliers among xjs, we
identify an outlier among xjsa s
|xj− median(x)|>3× mad(x)
where mad(x) is the median absolute deviation of x. Here, x is the vector of
all xjs. Note that the outliers can also be identiﬁed from the serial dilution
plot as points far away from the dilution curve (e.g. Fig. 3A).
Finally, we give the estimate of the dilution series as a weighted average
of xjs:
ˆ x=
 (xjwj)
 wj
(9)
where
wj=
1

∂xj
∂a  a
2
+

∂xj
∂M  M
2
+

∂xj
∂γ  γ
2 (10)
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the partial derivatives are derived and computed according to Equation (8);
 a,  M and  γ are standard deviations of a,M, γ, respectively, which are
obtained from the nls function in R. The estimated error of ˆ x is obtained
from ( wj)−1/2.
3 RESULTS
TotesttheutilityoftheserialdilutioncurveforanalyzingRPPAdata,
we ﬁrst applied the method to simulated data, which was composed
according to the Sips model [See Equation (2) in Section 2],
with background level a=100, saturation level M =50000 and
γ=1, dilution factor d =2. We added multiplicative noise (error
rate=0.15) to nominal signals and generated data as shown in
Figure 2A. The multiplicative error model has been previously
suggested (Kreutz et al., 2007). The samples were diluted to 1/2,
1/4and1/8oftheiroriginalconcentrationsserially.Figure2Bshows
the serial dilution plot, which contains all data in the dilution series.
Each point in the serial dilution plot is composed of an observed
signal at dilution step k (on y-axis) and a corresponding signal of
the same sample at the dilution step k+1 (on x-axis).
We found that our algorithm was able to recover the ‘true’
parameters from the simulated signals accurately. The values of
a, M and γ were found to be 98±5, 49800±520, 1.05±0.01,
respectively. The estimated protein concentrations are also accurate
(Figure 2C), except for the cases which are clearly out of the
linear range. The lower and the upper bound of the range were
calculated using Equations (6) and (7) and shown as dashed lines
in Figure 2C. Note that setting the lower and upper bound helps
to stabilize the estimates of protein concentration on logarithm
scale, so that small changes in observed signals do not incur large
changes in the estimates. Compare Figure 2A and C, one can also
see that the linear range is much wider in the latter, showing that the
dilution series can greatly expand the linear response range of the
measurements.
We have also tested our algorithm with experimental data.
Figure3showsatypicalexampleofRPPAdataset.Theexperimental
methods used to produce the array data were described by Fan
et al. (2007). From the serial dilution plot (Fig. 3A), we notice
many outliers (marked by red plus signs) near both x- and y-axis.
Inspection of the original scanned image revealed that these outliers
AB
CDE
Fig. 2. Computer simulations. (A) Computer generated data with serial dilutions. Red, yellow, green, blue represent undiluted concentrations, 1/2, 1/4, 1/8
original concentrations, respectively. (B) Serial dilution plot. The blue line shows the estimated serial dilution curve. (C) The estimated versus the ‘true’
concentrations. The dashed lines show the upper (shown in green) and lower (shown in blue) bounds of the estimated concentrations according to Equations
(5) and (6). The red line shows the identity lines. (D) Estimated error rates. CV=estimated error/estimated concentration. (E) Signal versus estimated
concentrations. Red, yellow, green, blue represent undiluted concentrations, 1/2, 1/4, 1/8 original concentrations, respectively.
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Fig. 3. Example of a practical dataset. The measured protein is beta actin, which serves as a control standard for measurements. (A) Serial dilution plot. Points
shown in red were regarded as outliers or saturated (circled). (B) Signal versus estimated concentration. The signals of undiluted samples are shown in red,
1/2 diluted samples in green and 1/4 diluted samples in blue. (C) Estimated error rates. CV=estimated error/estimated concentration. Each point represents
result from one serial dilution. (D) Estimated protein concentrations from replicated dilution series of the same samples.
were produced by a faulty background subtraction method that
extracted signals from the scanned image. The image quantiﬁcation
method took median pixel intensities from local regions outside
the spotted area as the background level. However, occasionally
the protein samples seemed to spill over the spotted area, which
caused grossly overestimated background levels, which in turn led
to grossly underestimated signals.
Figure 3A also showed that all the signals are bounded below
65000 (the points close to the upper bound are marked by the red
circles).This was caused by imaging software that set the maximum
pixel intensity to be 65536. Thus, the real signals must have been
truncated for these spots. We therefore removed the points shown in
redinFigure3Abeforeﬁttingtheserialdilutioncurve.Theestimated
parameters are a=5, M =63602, γ=0.57. The estimated protein
concentrations were shown in Figure 3B.
Sometimes RRPA experiment may fail to yield meaningful
measurements of proteins. In Figure 4, we show an example that
has quality problems. The experimental methods used to produce
the array data was described by Tibes et al. (2006). Using methods
as described in Section 2.2, the background was estimated to be
1000, saturation level: 4751, dilution factor: 1.11. The black line
is the identity line and the blue line is the serial dilution curve.
The serial dilution curve (blue) is very close to the identity line
(black), indicating that after dilution, the signals tend to stay at the
same levels as before. This implies that the dilution had failed to
produce the expected reduction of signals. The exact cause of this
effect is unclear. From our observations, such pattern often occurs
in the slides that have faint signals. Furthermore, because the serial
dilution curve is approximately linear, the saturation level cannot be
accurately determined.
To evaluate data quality on an array, we ﬁnd the following
two measures to be most important according to our empirical
experience.
(i) V1 = Percentage of data points in linear range (as deﬁned by
the interval [ar, M/r]) of all data points on the array, where
a is the background level, M is the saturation level, r is the
thresholdvalue(asdescribedearlier).HighV1valueindicates
goodqualityofdata.WhenV1islow,thedatapointsareoutof
the linear range, in which cases extra manipulation of protein
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Fig. 4. Example of data with quality problems. This is a serial dilution plot.
The measured protein is GAPDH. The red symbols show the outliers. The
background is estimated to be 1000, saturation level: 4751, dilution factor:
1.11. The black line is the identity line and the blue line is the serial dilution
curve.
concentration in the samples is needed prior to hybridization
on arrays.Alternatively, the level of antibody can be adjusted
so that more data points will may fall in the linear range. In
addition, note that the distribution of the data points can also
inform the signiﬁcance of non-linear effects. When most data
points are far below the saturation level, the serial dilution
curve approaches a straight line, in which case the saturation
level is uncertain (for example, see Fig. 4).
(ii) V2 = median CV on an array, where CV = estimated
error/estimated protein concentration. V2 represents
estimated error rate. High precision of protein concentration
measurements is represented by low V2 values.
4 DISCUSSION
Graphicaldisplayofdataplaysaveryimportantroleindataanalysis.
For RPPA data, it is conventional to plot the observed signals
against the estimated protein concentrations. However, because the
estimated protein concentrations depend on the models as well as
the estimated parameters, when the signals seem to ﬁt poorly to
the estimated concentrations, it is not clear whether it is due to
a suboptimal model or to noisy data. Making the serial dilution
plot per se requires no model selection or parameter ﬁtting. The
plot presents the entire set of observables on an array in their
original values. From the plot one can identify the background level,
saturation level, which signals are in the linear range, and which
signals are outliers (as in Fig. 3A). Fitting a serial dilution curve
needs only three parameters, which is much simpler than ﬁtting the
responsecurve,whichrequiresestimatingtheproteinconcentrations
as additional parameters.
From simulated RPPA data, we showed that our algorithm can
yield robust and accurate estimates of protein concentrations. From
practical RPPA data, we saw some of the data points did not
follow the serial dilution curve. There may be multiple causes of
the abnormal points, such as saturation or failure of binding. It
should be noted that the response curve in RPPA technology is
sensitive to a large number of factors, including the amount and
duration of sample incubation, speciﬁc and non-speciﬁc interactions
of reporter molecules and surface chemistry in the microarrays
(Seurynck-Servoss et al., 2007). These factors complicate the
interpretationofRPPAdata.Non-parametricmodels(Huetal,2007)
take fewer assumptions about the hybridization kinetics in RPPA
technology. Hence, the non-parametric models are more ﬂexible,
and in some cases they may ﬁt better with observed RPPAdata. The
disadvantage of non-parametric models is that the parameters are
less interpretable, while the parameters in Sips model are physically
meaningful and can be used to optimize the conditions for RPPA
experiments. We believe the method developed in this study will
have broad utility in RRPA applications.
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